Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation Via CCR5 Receptor in High-Fat Diet-Fed Mice
Overview
Chemistry
Molecular Biology
Affiliations
The C-C chemokine motif ligand 5 (CCL5) and its receptors have recently been thought to be substantially involved in the development of obesity-associated adipose tissue inflammation and insulin resistance. However, the respective contributions of tissue-derived and myeloid-derived CCL5 to the etiology of obesity-induced adipose tissue inflammation and insulin resistance, and the involvement of monocytic myeloid-derived suppressor cells (MDSCs), remain unclear. This study used CCL5-knockout mice combined with bone marrow transplantation (BMT) and mice with local injections of shCCL5/shCCR5 or CCL5/CCR5 lentivirus into bilateral epididymal white adipose tissue (eWAT). CCL5 gene deletion significantly ameliorated HFD-induced inflammatory reactions in eWAT and protected against the development of obesity and insulin resistance. In addition, tissue (non-hematopoietic) deletion of CCL5 using the BMT method not only ameliorated adipose tissue inflammation by suppressing pro-inflammatory M-MDSC (CD11bLy6GLy6C) accumulation and skewing local M1 macrophage polarization, but also recruited reparative M-MDSCs (CD11bLy6GLy6C) and M2 macrophages to the eWAT of HFD-induced obese mice, as shown by flow cytometry. Furthermore, modulation of tissue-derived CCL5/CCR5 expression by local injection of shCCL5/shCCR5 or CCL5/CCR5 lentivirus substantially impacted the distribution of pro-inflammatory and reparative M-MDSCs as well as macrophage polarization in bilateral eWAT. These findings suggest that an obesity-induced increase in adipose tissue CCL5-mediated signaling is crucial in the recruitment of tissue M-MDSCs and their trans-differentiation to tissue pro-inflammatory macrophages, resulting in adipose tissue inflammation and insulin resistance.
Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis.
Ion G, Bostan M, Hardman W, Putt McFarland M, Bleotu C, Radu N Int J Mol Sci. 2025; 26(5).
PMID: 40076892 PMC: 11899810. DOI: 10.3390/ijms26052275.
Rakib A, Mandal M, Mamun M, Kiran S, Yasmen N, Li L Front Immunol. 2025; 16:1501307.
PMID: 39967660 PMC: 11832521. DOI: 10.3389/fimmu.2025.1501307.
De Sanctis J, Balda Noria G, Garcia A Int J Mol Sci. 2025; 26(2).
PMID: 39859575 PMC: 11765591. DOI: 10.3390/ijms26020862.
Myeloid-Derived Suppressor Cells (MDSCs) and Obesity-Induced Inflammation in Type 2 Diabetes.
Ghemis L, Goriuc A, Minea B, Botnariu G, Martu M, Entuc M Diagnostics (Basel). 2024; 14(21).
PMID: 39518420 PMC: 11544947. DOI: 10.3390/diagnostics14212453.
The Role of Chemokines in Obesity and Exercise-Induced Weight Loss.
He W, Wang H, Yang G, Zhu L, Liu X Biomolecules. 2024; 14(9).
PMID: 39334887 PMC: 11430256. DOI: 10.3390/biom14091121.